<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:hpo ids='HP_0011009'>Acute</z:hpo> intracranial <z:hpo ids='HP_0000822'>hypertension</z:hpo> requires aggressive treatment with physiologic and pharmacologic measures guided by intracranial pressure monitoring devices </plain></SENT>
<SENT sid="1" pm="."><plain>Therapy involves the use of <z:chebi fb="40" ids="35498">diuretics</z:chebi>, <z:chebi fb="0" ids="50858">corticosteroids</z:chebi>, and <z:chebi fb="25" ids="22693">barbiturates</z:chebi> in combination with <z:hpo ids='HP_0002883'>hyperventilation</z:hpo>, ventricular drainage, and general supportive measures </plain></SENT>
<SENT sid="2" pm="."><plain>This review focuses on the pathophysiology of <z:hpo ids='HP_0002516'>increased intracranial pressure</z:hpo> and the pharmacologic agents used in its management </plain></SENT>
</text></document>